Houyi Biomedicine (Hangzhou) Co., Ltd. — founded by Academician Pei Duanqing, a skin life & health tech company built on regenerative medicine, powered by bioinformatics and AI skin large models.
Cellular-level skin revitalization, solving skin health from the root
Founded by Academician Pei Duanqing, building a skin regenerative medicine R&D system backed by Kuafu Biomedicine Laboratory. Houyi is essentially a "tech-output" biomedicine enterprise, deeply engaged in skin repair, wound healing and cell regeneration.
Building a globally open skin regenerative tech ecosystem, leading the industry.
Regenerative Medicine · Bioinformatics · AI Skin Large Model — three mutually-supporting foundations
Cell reprogramming · Stem cell exosomes · 3D bioprinting. Achieves structural regeneration of skin barrier, follicles and wound tissue; regulates skin microenvironment via paracrine effects to promote tissue repair.
Multi-omics analysis · Transcriptomics & proteomics · Microbiome. Precisely decodes molecular links between skin cells and micro-ecology.
Tens-of-millions database · Dual-mode algorithms · Microbiome data models. Integrates sequencing and facial imaging for precise skin assessment, intelligent repair planning and active-ingredient formulation optimization.
In-house science & translation platforms · Global research closed loop
Powered by bioinformatics
Key to regenerative medicine
Core of AI skin model
Solving industrialization bottlenecks
AI + bioinformatics fusion
Basic Research
Clinical Validation
Applied Translation
Tech Shareholder · Ingredients
Data-driven, reversible loop across three foundational techs
A clear linear closed loop from basic research to industrialization, ensuring every technology passes both scientific and market validation.
Explore cell regeneration
Decode micro life codes
Identify issues, generate solutions, build models
Iterative validation & efficacy testing
Assess safety & efficacy
Capture real response data
Solve scale-up challenges
Full rollout & dual validation
A complete path from basic research to industrialization, every step interdependent. Fully data-driven and traceable, forming a closed loop from market feedback to R&D optimization. B/C-end product feedback scales the data platform and refines models, creating a virtuous cycle.
B-end full-chain empowerment · C-end skin microbiome testing & AI skin analysis
Regenerative wound-healing ingredients · Microbiome bioinformatics testing · In-hospital AI skin SaaS. Elevating clinical treatment.
Post-procedure regenerative repair preparations · In-store dual-mode AI skin SaaS · Personalized post-procedure repair based on bio-data. Building differentiated competitiveness.
Regenerative ingredient R&D · Skin microbiome analysis · AI formulation support · Full-chain tech outsourcing (repair/anti-aging/microbiome). Comprehensive tech ecosystem output.
"Biotech + regenerative medicine + intelligent algorithms" driving precision skin health. Gene sequencing (micro) + AI vision (macro) cross-validation, producing visual causal analysis reports and personalized intervention plans based on regenerative medicine.
Full coverage of three foundational tech domains, building an independent IP barrier
Frontier layout: Electronic skin · Novel regenerative ingredients · Clinical regeneration · Industry standards
Flexible electronic skin monitoring devices powered by AI skin model and bioinformatics.
Continuous R&D of frontier ingredients via multi-omics screening, with customization and licensing.
Full-stack regenerative medicine for deep clinical translation on large-area skin defects.
Partnering with top-tier hospitals and university labs to lead industry standardization.
Serving skin health with regenerative medicine, bioinformatics and AI large models